Delft, Netherlands

Bart Van Hell

This inventor holds 2 USPTO granted patents. Top assignees: Gist-Brocades B.v., Gist-Brocades N.v.. Active years: 1997-1999.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1997-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Bart Van Hell: Innovator in Astaxanthin Production

Introduction

Bart Van Hell is a notable inventor based in Delft, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the production of astaxanthin, a valuable carotenoid with various applications.

Latest Patents

Bart Van Hell holds 2 patents related to strains of Phaffia rhodozyma. His latest patents include innovations that provide Phaffia rhodozyma strains containing high levels of astaxanthin. These strains are characterized by increased levels of astaxanthin and a low percentage of 3-hydroxy-3',4'-didehydro-.beta.,.psi.-caroten-4-one (HDCO). The methods for obtaining these strains involve a combination of mutagenesis and selection, which enhances their commercial viability.

Career Highlights

Throughout his career, Bart has worked with prominent companies such as Gist-Brocades B.V. and Gist-Brocades N.V. His work has focused on developing innovative solutions in the biotechnology sector, particularly in the enhancement of microbial strains for industrial applications.

Collaborations

Bart has collaborated with notable professionals in his field, including Lex De Boer and Andreas Jacobus Krouwer. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Bart Van Hell is a distinguished inventor whose work in the field of biotechnology has led to significant advancements in astaxanthin production. His innovative patents and collaborations highlight his commitment to enhancing industrial applications through scientific research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…